Twelve children with lla hypercholesterolaemia were given fenofibrate and examined after 6, 12 and 18 months of treatment. Cholesterol levels were measured both in whole plasma and in lipoprotein fractions after precipitation with concanavalin A. Plasma cholesterol and apoprotein B-bound cholesterol were reduced by 20% and 26% respectively (p less than 0.01). A non-significant 10% increase in apoprotein A-bound cholesterol was observed. These changes were effective at 6 months and persisted throughout the study. Fenofibrate was well tolerated and this, together with its effectiveness in lowering lipid values in hypercholesterolaemic children, suggests that it would be useful to achieve primary prevention.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[action fenofibrate
4
fenofibrate hypercholesterolemic
4
hypercholesterolemic children
4
children 18-month
4
18-month follow-up]
4
follow-up] twelve
4
twelve children
4
children lla
4
lla hypercholesterolaemia
4
hypercholesterolaemia fenofibrate
4

Similar Publications

Role of peroxisome proliferator-activated receptors α and γ in mediating the beneficial effects of β-caryophyllene in a rat model of fragile X syndrome.

Prog Neuropsychopharmacol Biol Psychiatry

January 2025

Dept. Science, Roma Tre University, Rome, Italy; Neuroendocrinology, Metabolism and Neuropharmacology Unit, IRCCS Fondazione Santa Lucia, Rome, Italy. Electronic address:

β-Caryophyllene (BCP) is a naturally occurring sesquiterpene found in numerous plant species, including Cannabis sativa. BCP has shown a high safety profile and a wide range of biological functions, including beneficial effects in neurodegenerative and inflammatory diseases. Here, we used behavioral, pharmacological, and in-silico docking analyses to investigate the effects and mechanism of action of BCP in Fragile X Syndrome (FXS), the most common inherited cause of Autism Spectrum Disorder (ASD) and intellectual disability.

View Article and Find Full Text PDF

Background: ()-5-hydroxy-7-methoxy-3-(2-hydroxybenzyl)-4-chromanone (HMC), a homoisoflavonoid isolated from , has significant anti-adipogenesis potential; it regulates adipogenic transcription factors. However, whether HMC improves hepatic steatosis in hepatocytes remains vague. This study investigated whether HMC ameliorates hepatic steatosis in free fatty acid-treated human hepatocellular carcinoma (HepG2) cells, and if so, its mechanism of action was analyzed.

View Article and Find Full Text PDF

Fenofibrate attenuates renal lipotoxicity in uninephrectomized mice with high-fat diet-induced obesity.

J Bras Nefrol

October 2024

Universidade Federal de Juiz de Fora, Centro de Biologia da Reprodução, Núcleo de Experimentação Animal, Laboratório de Nefrologia Experimental, Juiz de Fora, MG, Brazil.

Introduction: The objective of this study was to investigate the role of fenofibrate, a peroxisome proliferator-activated receptor-α agonist, in obesity-induced kidney damage (lipotoxicity) in mice with uninephrectomy.

Methods: C57BL/6 mice underwent uninephrectomy and sham surgeries and were fed normocaloric or high-fat diets. After 10 weeks, obese mice were administered 0.

View Article and Find Full Text PDF
Article Synopsis
  • Leonurine, a compound derived from the Lamiaceae plant, shows potential benefits in treating nonalcoholic fatty liver disease (NAFLD) due to its anti-oxidative, anti-apoptotic, and metabolic regulation properties, though its exact mechanisms are not fully understood.
  • In a study involving mice, different groups were treated with leonurine and other treatments to observe changes in liver health after a high-fat high-sugar diet, revealing that leonurine positively influenced lipid metabolism-related genes.
  • Further analysis indicated that leonurine may lower lipid levels by activating the AMPK signaling pathway and affecting lipid molecules, specifically through the ADRA1a/AMPK/SCD1 axis, thus improving liver lipid
View Article and Find Full Text PDF

Acceleration of HDL-Mediated Cholesterol Efflux Alleviates Periodontitis.

J Dent Res

October 2024

Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju, Republic of Korea.

Periodontitis (PD) is a common inflammatory disease known to be closely associated with metabolic disorders, particularly hyperlipidemia. In the current study, we demonstrated that hypercholesterolemia is a predisposing factor in the development of PD. Logistic regression analysis revealed a strong positive correlation between PD and dyslipidemia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!